BNP PARIBAS ARBITRAGE/CALL/PFIZER INC/28/0.1/20.09.24 | Market Closed - Euronext Paris 02:10:16 2024-05-22 EDT | ||
| 0.195 EUR | +5.41% |
|
| 1 month | +76.19% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
PFIZER, INC.
Latest news about PFIZER, INC.
More news
| Date | Price | Change |
|---|---|---|
| 24-05-22 | 0.195 | +5.41% |
| 24-05-21 | 0.185 | -5.13% |
| 24-05-20 | 0.195 | 0.00% |
| 24-05-17 | 0.195 | -9.30% |
| 24-05-16 | 0.215 | -4.44% |
Real-time Euronext Paris
Last update May 22, 2024 at 02:10 am
More quotesStatic data
| Product type | Plain-Vanilla-Warrants |
|---|---|
| Buy / Sell | CALL |
| Underlying | PFIZER, INC. |
| Issuer | 
BNP Paribas
|
| RA3NB | |
| ISIN | NLBNPFR1ZAQ9 |
| Date issued | 2024-03-06 |
| Strike | 28 $ |
| Maturity | 2024-09-20 (122 Days) |
| Parity | 10 : 1 |
| Emission price | 0.1 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 0.255 € |
|---|---|
| Lowest since issue | 0.08 € |
| Spread | 0.01 € |
| Spread % | 5.26% |
Company Profile
Pfizer, Inc. is the world's leading pharmaceutical group. Net sales break down by family of products as follows:
- primary care products (72.8%): medicines used in internal medicine, vaccines, medicines for the prevention and treatment of Covid-19, antivirals, mRNA-based products, etc.;
- specialty care products (13.8%): medicines used in immunology, in hospitals and for the treatment of rare diseases, anti-inflammatory medicines, etc.;
- oncology products (12.1%);
- other (1.3%).
At the end of 2022, the group had more than 35 manufacturing sites worldwide.
Net sales are distributed geographically as follows: the United States (42.3%), Europe (21.9%) and other (35.8%).
Sector
-
Consensus: Pfizer, Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
25
Last Close Price
28.56
USD
Average target price
31.94
USD
Spread / Average Target
+11.83%
- Stock Market
- Warrants
- RA3NB Warrant